Insulet | Işletim Giderleri



Operating Expenses Değişiklik Tarih
Abbott USD 8.7B 363M 2025-03
Align Technology USD 848.16M 2.91M 2025-03
AtriCure USD 129.57M 9.23M 2025-03
Avanos Medical USD 598.1M 439.7M 2024-12
Baxter International USD 3.19B 644M 2024-12
Becton, Dickinson and Co. USD 4.72B 74M 2024-12
Boston Scientific USD 3.74B 144M 2025-03
Cardinal Health USD 54.72B 3.01B 2024-12
Cooper Companies USD 782.7M 37.3M 2025-01
Dexcom USD 924.6M 82.4M 2024-12
Edwards Lifesciences USD 1.02B 55.3M 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Globus Medical USD 597.02M 19.41M 2024-12
ICU Medical USD 592.11M 11.22M 2024-12
Insulet USD 488.2M 32.4M 2024-12
Integra LifeSciences USD 407.42M 18.45M 2024-12
J&J USD 8.26B 10.37B 2025-03
Masimo USD 959.8M 485.3M 2024-12
Medtronic USD 6.65B 162M 2025-01
Merit Medical Systems USD 314.32M 4.28M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Solventum Corp 1.94B 131M 2024-12
Stryker USD 5.86B 1.45B 2024-12
Tandem Diabetes Care USD 355.3M 72.07M 2025-03
Teleflex USD 570.34M 335.45M 2025-03
West Pharmaceutical Services USD 591M 1.8M 2025-03
Zimmer Biomet Holdings USD 1.63B 89.5M 2024-12



Insulet Işletim Giderleri - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - May 2025.